Bizzell Releases Essential Opioid Overdose Response Video in Wake of National Crisis

Bizzell Releases Essential Opioid Overdose Response Video in Wake of National Crisis

January 22, 2024, New Carrollton, Maryland – As the opioid crisis continues to devastate communities with over 136 American deaths daily, primarily from fentanyl-laced drugs, Bizzell US (Bizzell) has developed and unveiled a vital educational tool. The company has released “Opioid 5 Steps to Respond to Opioid Overdose,” a video outlining critical steps to respond to an opioid overdose, developed under the guidance of leading experts in the field.

The video’s creation was informed by the extensive knowledge and experience of Bizzell’s team of specialists, including experts in health and human services, behavioral health, public health, substance use disorders, treatment and prevention, maternal and child health, medication-assisted treatment, mental health, and pharmacy operations. This collective expertise ensures that the video is not only informative but also grounded in the latest research and best practices.

Anton C. Bizzell, MD, Chairman and CEO, William H. Scarbrough, III, PhD, and Todd W. Mandell, MD are among some of notable experts at Bizzell who contributed their insights, reflecting decades of experience in fields relevant to opioid crisis management, behavioral health, and substance use disorders. Their involvement underscores Bizzell’s commitment to leveraging deep expertise in tackling this pressing public health issue.

This initiative is part of Bizzell’s broader effort to educate and empower individuals and communities in the fight against the opioid epidemic. The video is mandatory viewing for all Bizzell employees and is accompanied by a call to action to carry naloxone (Narcan), an effective emergency response medication now available over the counter.

The educational video will also be accessible on the Bizzell and the Behavioral Health Advancement Resource Center (BHARC) website, forming part of an informative mini-series on the opioid crisis.

About Bizzell US

Bizzell is a strategy, consulting, investment, & technology firm headquartered in New Carrollton, Maryland. Bizzell is a partner of choice for federal, state, and local government agencies, and private organizations. With a strong emphasis on innovation and impact, Bizzell transforms small ideas into powerful catalysts that drive change across markets worldwide. Learn more at www.BizzellUS.com.

About Behavioral Health Advancement Resource Center (BHARC)

Bizzell established the Behavioral Health Advancement Resource Center (BHARC) to provide expert information and resources to support the behavioral health community. With BHARC, Bizzell disseminates new ideas, tools, and solutions to critical behavioral health issues including the opioid epidemic, substance use disorders, suicide prevention, and more. As a leader in behavioral health initiatives, we bring together subject matter experts with exceptional experience, as well as commitment to behavioral health solutions.

For more information, visit www.bharc.org.

Bizzell Wins Two 2023 MUSE Creative Awards for Public Health Projects

Bizzell Wins Two 2023 MUSE Creative Awards for Public Health Projects

Bizzell was awarded two 2023 MUSE Creative Awards; a Gold award for a video and Silver award for a publication, both designed to support the National Institute on Drug Abuse Clinical Trials Network Dissemination Initiative, which aims to reduce the gap that exists between the publication of research on treatment of substance use disorders and implementation in clinical practice.

This year, Bizzell received the top honor of a Gold MUSE Creative Award in the Video-Educational category for the Reducing the Risks of Fentanyl in the U.S. This video was created in collaboration with the University of Pennsylvania Center for Addiction Medicine and Policy in response to rising rates of drug overdose deaths involving opioids. The video also stresses that everyone can be a first responder by carrying naloxone.

Bizzell also won a Silver MUSE Creative Award in the Publication category for the What is Fentanyl Infographic. This infographic was produced in response to the more than 80,000 opioid overdose deaths that occurred in 2020 driven by the illegally produced fentanyl that contaminates illegally produced opioids and benzodiazepines, as well as cocaine and synthetic cannabinoids. Additional information is provided regarding the impact of fentanyl on minorities, the need for broad-reaching awareness and education about the risks of fentanyl exposure, the warning signs of a possible overdose, how to reverse an overdose, and the use of naloxone.

About The MUSE Creative Awards

The MUSE Creative Awards is part of the MUSE Awards Program, which was created by the IAA in 2015. IAA’s inception was based on a mission to honor, promote and encourage creativity by providing a new standard of excellence for evaluation media design production and distribution. IAA’s mission has largely shaped MCA’s goal.

Website: MUSE Creative Awards

Supporting Drug Prevention Week

Supporting Drug Prevention Week

By Todd W. Mandel, MD, Bizzell US

National Prevention Week is a Substance Abuse and Mental Health Services Administration (SAMHSA) led national public education campaign highlighting the work of communities and organizations dedicated to raising awareness about substance misuse prevention and positive mental health. Observed May 7–13, this week-long endeavor encourages preventative initiatives and tactics designed to increase positive mental health outcomes.

This collaborative effort helps to strengthen prevention efforts and create a culture of health and wellness, bringing together individuals, organizations, and communities across the country. Please visit the Prevention Week homepage to register and join SAMHSA in honoring of the work of their partners in prevention and celebrating stories of success.

There are numerous dangers of substance use disorders (SUDs) that can affect both an individual’s physical and mental health. SUDs can cause changes in brain chemistry that can facilitate the development of mood disorders, anxiety, and depression. SUDs contribute to potentially fatal overdoses, and other issues such as heart disease, liver and kidney damage, and respiratory issues. Additionally, SUDs can disrupt personal relationships, cause financial problems, and even lead to legal issues.

According to the CDC figures cited by the Drug Enforcement Agency (DEA), 107,375 people in the United States died of drug overdoses and drug poisonings in the 12-month period ending in January 2022 [1]United States Drug Enforcement Administration. (2022, April 29). Fentanyl Awareness. Retrieved May 9, 2023, from https://www.dea.gov/fentanylawareness. A staggering 67 percent of those deaths involved synthetic opioids, like fentanyl, with some of these deaths attributed to fentanyl mixed with other illicit drugs like cocaine, methamphetamine, and heroin. This illicit mixture leaves many users unaware they were taking fentanyl, further contributing to overdoses. Only two milligrams of fentanyl can be a potentially lethal dose, particularly for someone who does not have an opioid tolerance. Recent data from the DEA indicates that Fentanyl is involved in more deaths of Americans under 50 than any cause of death, including heart disease, cancer, homicide, suicide, and accident-related deaths [1]United States Drug Enforcement Administration. (2022, April 29). Fentanyl Awareness. Retrieved May 9, 2023, from https://www.dea.gov/fentanylawareness.

While the focus of National Prevention Week is providing an educational forum to encourage people to not start using substances, for those who are already facing challenges with SUDs, effective treatments are available. There are also other strategies and resources for overdose prevention. Bizzell US, through its work with The National Institute on Drug Abuse Clinical Trials Network, produced online educational resources on topics for screening, fentanyl overdose prevention, and treatment for methamphetamine use disorder:

Prevention efforts such as education and awareness campaigns, early intervention programs, and easy access to treatment and support are essential to reduce drug use and its harmful consequences. By working together as a community to prioritize drug use prevention, we can help individuals and families avoid the devastating effects of drug addiction, promoting a safer and healthier future for everyone.

 

References

[1] United States Drug Enforcement Administration. (2022, April 29). Fentanyl Awareness. Retrieved May 9, 2023, from https://www.dea.gov/fentanylawareness.

 

3 Xanax Addiction Signs to Lookout For

3 Xanax Addiction Signs to Lookout For

Nearly 52 million Americans 18 and older are living with a mental illness and/or substance use disorder.  In the midst of the COVID-19 pandemic, reports of people suffering from panic disorders and anxiety are increasing. A common medication for treating panic disorders and anxiety is a prescription drug called Xanax. While Xanax can help relieve anxiety and panic symptoms, it is highly addictive. It is important that individuals taking Xanax become aware of the signs of an addiction to Xanax, which can include withdrawing from relationships and preoccupation with your Xanax use.  As individuals become preoccupied with maintaining a steady supply of Xanax, financial troubles and concerning behaviors may increase. In a recent WebMD Connect to Care article on signs of Xanax addiction, Dr. Anton C. Bizzell, CEO of The Bizzell Group and a substance abuse expert, highlighted some additional telltale signs: “Maintaining a supply of the drug on hand, mixing with alcohol or other drugs, and developing dangerous behaviors to obtain the prescription, including stealing or getting it from the streets.”

Recognizing the signs of an addiction is an important step towards getting help to treat an addiction—for yourself or others you love.

READ MORE: 3 Xanax Addiction Signs to Lookout For